These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 15944310)
1. Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. Ajuebor MN; Aspinall AI; Zhou F; Le T; Yang Y; Urbanski SJ; Sidobre S; Kronenberg M; Hogaboam CM; Swain MG J Immunol; 2005 Jun; 174(12):8027-37. PubMed ID: 15944310 [TBL] [Abstract][Full Text] [Related]
2. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen. Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017 [TBL] [Abstract][Full Text] [Related]
3. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. Maeda M; Shadeo A; MacFadyen AM; Takei F J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797 [TBL] [Abstract][Full Text] [Related]
4. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663 [TBL] [Abstract][Full Text] [Related]
6. A role for CD1d-restricted NKT cells in injury-associated T cell suppression. Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771 [TBL] [Abstract][Full Text] [Related]
8. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice. Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262 [TBL] [Abstract][Full Text] [Related]
9. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921 [TBL] [Abstract][Full Text] [Related]
10. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4. Kim JH; Choi EY; Chung DH J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047 [TBL] [Abstract][Full Text] [Related]
11. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. Lisbonne M; Diem S; de Castro Keller A; Lefort J; Araujo LM; Hachem P; Fourneau JM; Sidobre S; Kronenberg M; Taniguchi M; Van Endert P; Dy M; Askenase P; Russo M; Vargaftig BB; Herbelin A; Leite-de-Moraes MC J Immunol; 2003 Aug; 171(4):1637-41. PubMed ID: 12902459 [TBL] [Abstract][Full Text] [Related]
12. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. Pellicci DG; Hammond KJ; Coquet J; Kyparissoudis K; Brooks AG; Kedzierska K; Keating R; Turner S; Berzins S; Smyth MJ; Godfrey DI J Immunol; 2005 Oct; 175(7):4416-25. PubMed ID: 16177083 [TBL] [Abstract][Full Text] [Related]
13. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360 [TBL] [Abstract][Full Text] [Related]
14. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. Oh K; Kim S; Park SH; Gu H; Roopenian D; Chung DH; Kim YS; Lee DS J Immunol; 2005 Feb; 174(4):2030-6. PubMed ID: 15699132 [TBL] [Abstract][Full Text] [Related]
15. A cell-type specific CD1d expression program modulates invariant NKT cell development and function. Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169 [TBL] [Abstract][Full Text] [Related]
16. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408 [TBL] [Abstract][Full Text] [Related]
17. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells. Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Taniguchi M; Faunce DE J Immunol; 2006 Jul; 177(1):92-9. PubMed ID: 16785503 [TBL] [Abstract][Full Text] [Related]
18. Control of NKT cell differentiation by tissue-specific microenvironments. Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102 [TBL] [Abstract][Full Text] [Related]
19. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]